Insights into COVID-19’s aftermath: 2-year study examines lasting health effects

Researchers comprehensively assessed the risks and burdens of post-acute sequelae of coronavirus disease 2019.

Is $13B Devoted Health succeeding where other insurance upstarts have failed?

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 14, 2024

Study reveals key role of A20 protein in controlling inflammation in liver disease

Many individuals worldwide suffer from chronic liver disease (CLD), which poses significant concerns for its tendency to lead to hepatocellular carcinoma or liver failure. CLD

August 29, 2024

Significant earnings improvement in 2023; e-prescription is standard in Germany – Biotech Investments

DocMorris AG / Key word(s): Annual Results 21-March-2024 / 06:58 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

March 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.